· The UK and Europe's drug regulators have found a possible link between AstraZeneca's Vaxzevria shots and rare blood clots in adults who had received the inoculation. The head of the European Medicines Agency (EMA) stressed the risk of mortality from COVID-19 w...
AstraZeneca’s chief medical officer, Ann Taylor, said: "Around 17 million people in the EU and UK have now received our vaccine, and the number of cases of blood clots reported in this group is lower than the hundreds of...
· Europe's drug regulator is expected to make a recommendation on Johnson & Johnson's vaccine next weekafter U.S. health agencies paused the jab's use after reports of rare disorder involving blood clots. For now, the European Medicines Agency says its benefits outwei...
Disorders caused by blood clots, including heart attacks, vein thromboses, and strokes, are common. But the types of clots that may be linked to the AstraZeneca vaccine are exceedingly rare. They have been marked by low levels of platelets — the blood cell fragments that normally cause clotti...
The vaccine-induced immune thrombocytopenia and thrombosis (VITT) a situation where low platelet count combines with blood clots is considered as a rare side effect of vector-based COVID-19 vaccines such as those from Astra (AZN) and Johnson & Johnson . ...
COVID-19 is associated with a risk of hospitalisation and death. The reported combination of blood clots and low blood platelets is very rare, and the overall benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects. ...
There is no indication that the Oxford-AstraZeneca Covid-19 vaccine is linked to an increased risk of blood clots, the EU's medicines regulator says. It said the number of cases in vaccinated people was no higher than in the general population. ...
Indonesia has temporarily postponed the distribution of COVID-19 vaccines developed by Oxford University in collaboration with a British multinational pharmaceutical company AstraZeneca following reports of blood clots in several European countries, an official said on Tuesday. ...
The decision came months after the British-Swedish pharma giant admitted the drug could cause very rare but life-threatening injuries such as blood clots and low blood platelet counts. The European Medicines Agency also announced the withdrawal, Worthy News observed, which means that the Vaxzevria...
Wednesday’s update comes the day after the Public Health Agency of Canada was alerted of the first case of blood clots in a Quebec woman who had received the AstraZeneca vaccine. She has been treated and is recovering at home. Sharma said that her agency still believes that “the benef...